To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Tripos Announces Benchware Discovery 360º
Tripos, Inc. has announced Benchware® Discovery 360º, a software solution designed to enable discovery scientists to access and analyze enterprise wide chemical and biological research data from within a single integrated desktop discovery environment.
Benchware Discovery 360º was unveiled at the Drug Discovery Technology® & Development World Congress in Boston.
Benchware Discovery 360º is designed to provide scientists and research managers with a single point of entry from which they can access, analyze and share data from disparate enterprise repositories of biological and chemical data.
In addition, Benchware Discovery 360º integrates with applications from other vendors, providing researchers access to their favorite analysis and productivity tools.
These capabilities enable life science organizations to gain better insight into their drug discovery projects, improve scientific collaboration, and allow discovery teams to fully realize the value in the data they are generating.
Benchware Discovery 360º is based on the SMART-IDEA™ informatics system that Tripos originally built in collaboration with Bristol-Myers Squibb Co., and which is also forming the basis of a next-generation discovery IT solution, announced earlier this year, for Wyeth Pharmaceuticals.
"Many of today’s discovery data warehouse solutions require chemists and biologists to become information technology specialists instead of more informed and agile discovery scientists," said Bryan Koontz, senior vice president and general manager of Discovery Informatics for Tripos.
"Instead of wasting valuable time formulating complicated queries or being forced to become Microsoft Excel experts, project teams using Benchware Discovery 360º can now quickly find, analyze and act on the research data they need, no matter where it exists inside their company."
"The result is a substantial improvement to a company’s overall discovery performance."